AbbVie Petition: Drug Hazards are not Trade Secrets

September 1, 2013

1 Sep – Drug companies maximize the sales of new drugs by hyping their benefits while downplaying their significant risks.  In 2010 the European Medicines Agency began releasing patient-level data from the clinical trials used to approve new medicines in Europe – a development hailed by American, and European researchers and researchers around the world as a major step towards drug safety.

(Please SIGN THIS PETITION and repost it on your listservers and social marketing pages to alert people around the world about this pharmaceutical threat.)

Humira-side-effectsThis process has been shut down by a lawsuit taken by two American corporations – AbbVie, makers of Humira, the number one selling medication in the world with projected sales of $10 billion in 2013; and InterMune, whose pulmonary-fibrosis drug Esbriet has recently been approved in Europe at a cost of over $40,000 per year.  Patients have already been injured by Humira.

AbbVie and InterMune have filed suit to deny access to the data from their trials on the benefits and harms of these drugs, claiming these vital facts are “trade secrets” whose release would harm their profits. Their action has led to the shutdown of the entire public-access program, leaving millions of patients worldwide, and their doctors, in the dark.

CONTEXT

Since 2009, the pharmaceutical industry has paid $10 billion to settle thousands of criminal and civil complaints related to the illegal marketing of drugs that kill or injure 2-4 million Americans, ANNUALLY.  If we extrapolate those injuries and deaths to the global population that is exposed to these drugs and vaccines, that number is likely to be much higher.  To promote dangerous drugs and vaccines, drug companies pay billions of dollars in kickbacks and bribes to clinicians who unnecessarily prescribe deadly drugs and vaccines to their healthy and vulnerable patients.

Companies that kill for profit are typically characterized as “criminal enterprises.”

esebriOMSJ joins RXisk’s call on AbbVie and InterMune to drop their European Union lawsuit and release all patient level data on Humira, Esbriet and their other products. Vital data on drug safety should never be hidden as a “trade secret” (especially by industries that are known to suppress information about toxic products that injure and kill.  By copying and signing this petition to President Barack Obama and members of his Cabinet, we call on them to ensure that meaningful public access to clinical trial data becomes the policy of the FDA and is written into any international trade agreements governing the sale of prescription drugs and devices.

RxISK.org has started this petition called “Richard Gonzalez of AbbVie, and Daniel Welch of InterMune: Drop your legal action blocking access to EMA clinical trial data“.   This is not a Western issue only – EMA give access to the data to researchers from all over the world.  At present only 15 of 1500 signatures are from outside the West.

WHAT CAN YOU DO?

Please SIGN THIS PETITION and repost it on your listservers and social marketing pages to alert people around the world about this pharmaceutical threat.

Here’s the content:

***

Let us see Drug Data! Drug hazards are not “trade secrets”!

Drug companies maximize the sales of new drugs by hyping their benefits while downplaying significant risks. In 2010 the European Medicines Agency began releasing patient-level data from the clinical trials used to approve new medicines in Europe – a development hailed by American, and European researchers and researchers around the world as a major step towards drug safety.

This process has been shut down by a lawsuit taken by two American corporations – AbbVie, makers of Humira, the number one selling medication in the world with projected sales of $10 billion in 2013; and InterMune, whose pulmonary-fibrosis drug Esbriet has recently been approved in Europe at a cost of over $40,000 per year.

AbbVie and InterMune have filed suit to deny access to the data from their trials on the benefits and harms of these drugs, claiming these vital facts are “trade secrets” whose release would harm their profits. Their action has led to the shutdown of the entire public-access program, leaving millions of patients worldwide, and their doctors, in the dark.

We call on AbbVie and InterMune to drop their European Union lawsuit and release all patient level data on Humira, Esbriet and their other products. Vital data on drug safety should never be hidden as a “trade secret.” By copying this petition to President Barack Obama and members of his Cabinet we call on them to ensure that meaningful public access to clinical trial data becomes the policy of the FDA and is written into any international trade agreements governing the sale of prescription drugs and devices.

Copies to:
President Barack Obama;
Margaret Hamburg, M.D., Commissioner, Food & Drug Administration;
Secretary General Ban Ki Moon, United Nations;
World Health Organization Director Dr Margaret Chan.

You can sign the RxISK petition by clicking here.

Tags: , , , , , , , , , , ,

You must be logged in to comment

Log in